{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:17:17Z","timestamp":1791825437564,"version":"4.3.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/inf.0b013e3181927891","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T10:30:07Z","timestamp":1242901807000},"page":"445-447","source":"Crossref","is-referenced-by-count":18,"title":["DAPTOMYCIN THERAPY FAILURE IN AN ADOLESCENT WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS BACTEREMIA"],"prefix":"10.1097","volume":"28","author":[{"given":"Lara M.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Milstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Zenilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen C.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravit","family":"Arav-Boger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-22-20210202","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant Staphylococcus aureus (MRSA) blood isolates from 2001\u201305.","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R3-22-20210202","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-22-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/dkm137","article-title":"Daptomycin for endocarditis and\/or bacteraemia: a systematic review of the experimental and clinical evidence.","volume":"60","author":"Falagas","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R5-22-20210202","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/INF.0b013e31814523f8","article-title":"Daptomycin therapy for invasive Gram-positive bacterial infections in children.","volume":"26","author":"Ardura","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R6-22-20210202","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/INF.0b013e318160edfc","article-title":"Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.","volume":"27","author":"Abdel-Rahman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R7-22-20210202","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1592\/phco.26.5.694","article-title":"Pharmacokinetics of daptomycin in a critically ill adolescent with vancomycin-resistant enterococcal endocarditis.","volume":"26","author":"Akins","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R8-22-20210202","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.jp.7211898","article-title":"Daptomycin use in infants: report of two cases with peak and trough drug concentrations.","volume":"28","author":"Cohen-Wolkowiez","year":"2008","journal-title":"J Perinatol"},{"key":"R9-22-20210202","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1128\/AAC.01321-07","article-title":"Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury.","volume":"52","author":"Mohr","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-22-20210202","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jac\/dkm170","article-title":"Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies.","volume":"60","author":"Rose","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R11-22-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2004.07.002","article-title":"Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.","volume":"50","author":"Sader","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R12-22-20210202","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","article-title":"Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.","volume":"43","author":"Hayden","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R13-22-20210202","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/JCM.01844-07","article-title":"Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.","volume":"46","author":"Huang","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R14-22-20210202","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.diagmicrobio.2007.11.002","article-title":"Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.","volume":"60","author":"Bennett","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R15-22-20210202","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/502688","article-title":"Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia.","volume":"27","author":"Hirschwerk","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R16-22-20210202","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.00559-07","article-title":"Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.","volume":"51","author":"Julian","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-22-20210202","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1086\/428616","article-title":"Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.","volume":"40","author":"Mangili","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R18-22-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jac\/dkl256","article-title":"Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.","volume":"58","author":"Mariani","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R19-22-20210202","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","article-title":"Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.","volume":"44","author":"Marty","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R20-22-20210202","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10096-007-0455-5","article-title":"High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia.","volume":"27","author":"Sharma","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R21-22-20210202","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1099\/jmm.0.2008\/000588-0","article-title":"Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate.","volume":"57","author":"Murthy","year":"2008","journal-title":"J Med Microbiol"},{"key":"R22-22-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jinf.2007.05.180","article-title":"Daptomycin.","volume":"55","author":"Enoch","year":"2007","journal-title":"J Infect"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200905000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:50:18Z","timestamp":1786038618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200905000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181927891","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}